ストックスクリーナーアプリを入手
74.67
0.46%
0.34
Cg Oncology Inc (CGON) 最新ニュース
RTW INVESTMENTS, LP Boosts CG Oncology Inc (CGON) Stake -- Shares Look 38% Undervalued on GF Value - GuruFocus
Jefferies Group's CG Oncology Inc(CGON) Holding History - GuruFocus
Investigation launched into CG Oncology officers for possible self-dealing harming shareholders - Pluang
Kuehn Law Encourages Investors of CG Oncology, Inc. to Contact Law Firm - PR Newswire
How Investors May Respond To CG Oncology (CGON) Revenue Growth Alongside a Widening Net Loss - simplywall.st
CG Oncology (NASDAQ: CGON) insider flags $7.95M stock sale after recent disposals - Stock Titan
CG Oncology stock hits all-time high of 79.5 USD By Investing.com - Investing.com Nigeria
CG Oncology stock hits all-time high of 79.5 USD - Investing.com
CG Oncology (NASDAQ:CGON) Flaunts a Perfect Technical Breakout Setup - ChartMill
CG Oncology director sells 1,000 shares at $74.54 | CGON Insider Trading - Stock Titan
Midday Stock Roundup: Eledon Falls 3.5% - Orange County Business Journal
CG Oncology (NASDAQ: CGON) insider lines up new stock sale - Stock Titan
CGON shareholder (NASDAQ: CGON) details planned 19,364-share stock sale - Stock Titan
CG Oncology (CGON) sees Foresite Capital report 4.9% beneficial stake via funds - Stock Titan
CG Oncology (CGON): RTW Investments takes 9.7% position, holding 8.5M shares - Stock Titan
CG Oncology's bladder cancer drug shows strong results with 75% response rate and no severe side effects. - Pluang
CG Oncology: Circling Back After Huge Rally - Seeking Alpha
CGON (CGON) investor lists 25,989-share sale after series of stock disposals - Stock Titan
CG Oncology (CGON) Falls 2.96% as Shares Approach Key Support at $70.97Institutional Volume - Vinanet
CG Oncology (CGON): Wellington group discloses 5.3M-share, 6.04% ownership position - Stock Titan
Truist Financial Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $85 - Moomoo
CGON (NASDAQ: CGON) holder files to sell 32,137 shares after option exercise - Stock Titan
CGON (CGON) insider Ambaw Bellete plans 50,000-share stock sale - Stock Titan
CG Oncology (NASDAQ:CGON) Hits New 52-Week HighShould You Buy? - marketbeat.com
CG Oncology, Inc. (CGON) Stock Analysis: A Potential 18.96% Upside In The Biotech Sector - DirectorsTalk Interviews
CGON (CGON) insider plans 50,000-share stock sale after option exercise - Stock Titan
HC Wainwright Has Weak Estimate for CG Oncology Q3 Earnings - MarketBeat
CG Oncology Inc (CGON) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
A Quick Look at Today's Ratings for CG Oncology(CGON.US), With a Forecast Between $85 to $108 - Moomoo
Enterprise value to EBITDA forward of CG Oncology, Inc. – NASDAQ:CGON - TradingView
Bank of America Securities Reaffirms Their Buy Rating on CG Oncology, Inc. (CGON) - The Globe and Mail
Bank of America Corp DE Grows Holdings in CG Oncology, Inc. $CGON - MarketBeat
Wall Street Zen Downgrades CG Oncology (NASDAQ:CGON) to Strong Sell - MarketBeat
CG Oncology (NASDAQ:CGON) Posts Earnings Results, Misses Expectations By $0.24 EPS - MarketBeat
Insider Ambaw Bellete plans CGON (CGON) stock sale after large prior trades - Stock Titan
Royal Bank Of Canada Has Lowered Expectations for CG Oncology (NASDAQ:CGON) Stock Price - MarketBeat
Piper Sandler Issues Positive Forecast for CG Oncology (NASDAQ:CGON) Stock Price - MarketBeat
Truist Financial Issues Positive Forecast for CG Oncology (NASDAQ:CGON) Stock Price - marketbeat.com
A Quick Look at Today's Ratings for CG Oncology(CGON.US), With a Forecast Between $79 to $100 - moomoo.com
BofA Adjusts Price Target on CG Oncology to $88 From $87 - Moomoo
RBC Adjusts PT on CG Oncology to $79 From $81, Maintains Outperform Speculative Risk Rating - marketscreener.com
FY2029 EPS Estimates for CG Oncology Cut by HC Wainwright - MarketBeat
How Investors Are Reacting To CG Oncology (CGON) Wider Quarterly Loss Amid Promising Phase 3 Bladder Cancer Data - simplywall.st
CG ONCOLOGY Q2 NET INCOME USD -79.1 MILLION - Moomoo
CG Oncology, Inc. Stock 12‑Month Price Target Raised to $91.15, Implies 26% Upside - TradingView
Insider (NASDAQ: CGON) files to sell 75,000 shares after recent stock sales - Stock Titan
CG Oncology earnings up next amid bladder cancer therapy push By Investing.com - Investing.com Nigeria
CG Oncology earnings up next amid bladder cancer therapy push - Investing.com
CG Oncology Announces Q2 2026 Financial Results with Increased Revenues and Expanded Marketable Securities - Kalkine Media
CG Oncology Announces Q2 2026 Earnings and Boosts ATM Equity Offering by $500 Million - Kalkine Media
CG Oncology, Inc. reports results for the quarter ended June 30Earnings Summary - tradingview.com
CG Oncology Q2 Net Loss Widens - marketscreener.com
CG Oncology, Inc. (CGON) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Earnings Flash (CGON) CG Oncology Posts Q2 Net Loss $0.90 a Share, vs. FactSet Est of $0.66 Loss - marketscreener.com
Earnings Flash (CGON) CG Oncology, Inc. Reports Q2 Revenue $1.2M - marketscreener.com
CG Oncology (NASDAQ: CGON) posts $139.3M half-year loss with $1,028.3M cash - Stock Titan
CG Oncology posts Q2 loss as bladder cancer milestones approach - Quiver Quantitative
CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates - The Manila Times
CG Oncology Q2 net loss widens on higher R&D costs - TradingView
CG Oncology expects bladder cancer trial data soon; cash through 2029 - Stock Titan
CG Oncology publishes investor deck highlighting cretostimogene data in high-risk NMIBC programs - Bitget
CGON (CGON) insider Ambaw Bellete plans 25,000-share stock sale via broker - stocktitan.net
0.86%
0.31%
大文字化:
|
ボリューム (24 時間):